JP4119440B2 - Iron-added whey protein concentrate and method for producing the same - Google Patents

Iron-added whey protein concentrate and method for producing the same Download PDF

Info

Publication number
JP4119440B2
JP4119440B2 JP2005185338A JP2005185338A JP4119440B2 JP 4119440 B2 JP4119440 B2 JP 4119440B2 JP 2005185338 A JP2005185338 A JP 2005185338A JP 2005185338 A JP2005185338 A JP 2005185338A JP 4119440 B2 JP4119440 B2 JP 4119440B2
Authority
JP
Japan
Prior art keywords
iron
whey
added
wpc
whey protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2005185338A
Other languages
Japanese (ja)
Other versions
JP2007000094A (en
Inventor
智木 中野
十成 中冶
倫美 後藤
Original Assignee
南日本酪農協同株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 南日本酪農協同株式会社 filed Critical 南日本酪農協同株式会社
Priority to JP2005185338A priority Critical patent/JP4119440B2/en
Publication of JP2007000094A publication Critical patent/JP2007000094A/en
Application granted granted Critical
Publication of JP4119440B2 publication Critical patent/JP4119440B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dairy Products (AREA)

Description

本発明は鉄添加ホエー蛋白質濃縮物(以下、WPCと略記する場合がある)、さらに詳しくは、鉄欠乏性貧血の予防および改善、鉄強化を目的とした食品、医薬品等の原料として有用な鉄添加WPCおよびその製造法に関する。   The present invention relates to an iron-added whey protein concentrate (hereinafter sometimes abbreviated as WPC), more specifically, iron useful as a raw material for foods, pharmaceuticals and the like for the purpose of prevention and improvement of iron deficiency anemia and iron fortification. The present invention relates to an added WPC and a method for producing the same.

近年、鉄摂取不足により貧血症状を起こす女性が数多く見られる。この傾向は、思春期の女子や若い女性において特に顕著である。鉄欠乏性貧血の原因としては、食生活に由来する点が最も大きいが、女性の場合は月経による出血、妊娠による需要の増加、および過度なダイエットによる鉄摂取不足等により鉄欠乏の状態に陥り、貧血になりやすい環境下にある。
一般に約50%の女性は何らかの形で鉄欠乏の状態にあると言われている。この鉄欠乏を解消するために貧血傾向の人や、妊産婦を対象とした鉄強化食品が販売されるようになってきており、牛乳、清涼飲料水に鉄分を強化した商品も多数販売され始めている。例えば清涼飲料水に添加する鉄添加剤としては、乳酸鉄、クエン酸第一鉄ナトリウム、クエン酸コハク酸鉄ナトリウム等の水溶性の有機酸鉄塩が使用されているが、これらは鉄味が強く、嗜好性の問題で、一度にあまり多くの量を使用できないという問題がある。また、有機鉄のヘム鉄も鉄味や血液由来の血生臭さといった風味上の問題があり、飲食品等への添加には制約がある。ピロリン酸第2鉄などの水不溶性および難溶性鉄塩を用いた場合、鉄味は改善されるものの、比重が2.75以上と高く、清涼飲料水等に分散させた場合、液中で短時間に沈殿し、懸濁安定性に問題がある。さらに、鉄の吸収を促進する目的で、炭酸イオン存在下で鉄とラクトフェリンの複合体を調製し食品に添加している(特許文献1および2参照)。しかし、ラクトフェリンは食品素材として高価でありコストの面で問題がある。
一方、ホエーはチーズやカゼインを製造の副産物で、タンパク質、ミネラル、乳糖などが豊富に含まれている。チーズホエーからホエータンパク質を濃縮したWPCや、イオン交換樹脂吸着法を行ったのちに濃縮、乾燥させた単離ホエータンパク質(WPI)はカゼインと比べてアミノ酸組成に優れており、栄養価値が高くしかも安価な食品素材として幅広く利用されている。しかし、近年、チーズの消費量増加に伴いホエーの生産量も増加しており、環境保護や資源の有効利用の面からも更なる利用方法の開発が必要とされている。
ホエーを利用した鉄剤として、ホエータンパク質をタンパク加水分解酵素で加水分解したホエータンパク質加水分解物と鉄の複合体が提案されている(特許文献3参照)。
特公平6−21077号公報 特開平7−304798号公報 特開2000−50812号公報
In recent years, many women have developed anemia due to insufficient iron intake. This trend is particularly noticeable in adolescent girls and young women. The most common cause of iron deficiency anemia is due to dietary habits, but women suffer from iron deficiency due to bleeding due to menstruation, increased demand due to pregnancy, and insufficient iron intake due to excessive dieting. The environment is prone to anemia.
In general, about 50% of women are said to be somehow iron deficient. In order to eliminate this iron deficiency, iron-enriched foods for people who are anemic and for pregnant women are being sold, and many products with enhanced iron content in milk and soft drinks are also on sale. . For example, as iron additives to be added to soft drinks, water-soluble organic acid iron salts such as iron lactate, sodium ferrous citrate, and iron iron citrate are used. There is a problem that it is not possible to use a large amount at a time because of a strong taste problem. Moreover, organic iron heme iron also has a flavor problem such as iron taste and bloody odor derived from blood, and its addition to foods and drinks is restricted. When water-insoluble and poorly soluble iron salts such as ferric pyrophosphate are used, the iron taste is improved, but the specific gravity is as high as 2.75 or more, and when dispersed in soft drinks, etc., it is short in the liquid. It settles over time and there is a problem with suspension stability. Furthermore, for the purpose of promoting iron absorption, a complex of iron and lactoferrin is prepared in the presence of carbonate ions and added to food (see Patent Documents 1 and 2). However, lactoferrin is expensive as a food material and has a problem in terms of cost.
On the other hand, whey is a by-product of manufacturing cheese and casein, and is rich in protein, minerals, lactose and the like. WPC that concentrates whey protein from cheese whey and isolated whey protein (WPI) that is concentrated and dried after the ion exchange resin adsorption method has superior amino acid composition and high nutritional value compared to casein. Widely used as an inexpensive food material. However, in recent years, whey production has increased as cheese consumption has increased, and further development of methods of use is required from the viewpoint of environmental protection and effective use of resources.
As an iron agent using whey, a complex of whey protein hydrolyzate obtained by hydrolyzing whey protein with a protein hydrolase and iron has been proposed (see Patent Document 3).
Japanese Patent Publication No.6-21077 JP-A-7-304798 JP 2000-50812 A

本発明は、チーズやカゼインの副産物として生じるホエーを有効利用し、鉄の吸収性・貧血改善効果に優れた鉄添加WPCおよびその製造法を提供することを目的とする。   An object of the present invention is to provide an iron-added WPC excellent in iron absorption and anemia improvement effects and a method for producing the same, by effectively using whey produced as a by-product of cheese and casein.

本発明者らはチーズやカゼインを製造する際に生じるホエーの新しい利用技術について検討を進めていたところ、タンパク加水分解酵素による処理をしなくても、鉄添加ホエータンパク質濃縮物(WPC)が、鉄の吸収性・貧血改善効果に優れた鉄剤となること、また、鉄添加WPCは鉄を高い比率で含有するにもかかわらず、鉄の収斂味を有していないことを見いだし、本発明を完成するに至った。
すなわち、本発明は、
(1)ホエータンパク質1重量部当たり、0.001〜0.05重量部の鉄を含有し、鉄の収斂味を有さないことを特徴とする鉄添加ホエータンパク質濃縮物、
(2)pHが5.5以上の液状またはその乾燥物である上記(1)記載の濃縮物、
(3)鉄の吸収性、貧血改善効果用である上記(1)記載の濃縮物、
(4)ホエーと、鉄イオンを含む水溶液を混合して限外濾過するか、限外濾過したホエーと、鉄イオンを混合することを特徴とする上記(1)記載の鉄添加ホエータンパク質濃縮物の製造法、
(5)鉄イオンの重量がホエー中のタンパク質の1/20以下、得られるホエーと鉄イオンの液状混合物のpHが5.5以上である上記(4)記載の製造法等を提供するものである。
The inventors of the present invention have been studying a new utilization technology of whey produced when producing cheese and casein. Even without treatment with protein hydrolase, iron-added whey protein concentrate (WPC) It has been found that the iron agent is excellent in iron absorption and anemia improvement effects, and that the iron-added WPC does not have iron astringency even though it contains iron in a high ratio. It came to be completed.
That is, the present invention
(1) An iron-added whey protein concentrate containing 0.001 to 0.05 parts by weight of iron per part by weight of whey protein and having no iron astringent taste,
(2) The concentrate according to (1) above, which is a liquid having a pH of 5.5 or higher or a dried product thereof,
(3) The concentrate according to the above (1), which is for iron absorption and anemia improvement effect,
(4) The iron-added whey protein concentrate according to (1) above, wherein the whey and an aqueous solution containing iron ions are mixed and ultrafiltered, or the ultrafiltered whey and iron ions are mixed. Manufacturing method,
(5) The production method according to the above (4), wherein the weight of iron ions is 1/20 or less of the protein in whey, and the pH of the liquid mixture of whey and iron ions obtained is 5.5 or more. is there.

本発明の鉄添加WPCは、ホエーと鉄を混合するという簡単な方法で製造でき、得られた鉄添加WPCは、鉄−ホエータンパク質複合体を形成し、溶解性に優れ、鉄独特の収斂味がないので、鉄欠乏性貧血の予防あるいは改善、鉄強化を目的とした食品、医薬品、飼料等の原料として有用である。   The iron-added WPC of the present invention can be produced by a simple method of mixing whey and iron. The obtained iron-added WPC forms an iron-whey protein complex, has excellent solubility, and has a unique astringent taste of iron. Therefore, it is useful as a raw material for foods, pharmaceuticals, feeds, etc. for the purpose of preventing or improving iron deficiency anemia and strengthening iron.

本発明の鉄添加WPCは、ホエータンパク質1重量部当たり、0.001〜0.05重量部、好ましくは0.005〜0.03重量部の鉄を含有する。このような鉄添加WPCは鉄独特の収斂味がなく、鉄の吸収性・貧血改善効果に優れていることが判明した。
用いるホエーは特に限定するものではなく、チーズおよびカゼイン製造の際に生じたホエーはもとより、乾燥したホエーを再度水に溶解して復元したものでもよい。
鉄源としては、通常、塩化第二鉄、硝酸第二鉄、硫酸第二鉄等の鉄化合物が使用でき、例えば、これらは水溶液の形態で使用される。
The iron-added WPC of the present invention contains 0.001 to 0.05 parts by weight, preferably 0.005 to 0.03 parts by weight of iron per 1 part by weight of whey protein. It was found that such iron-added WPC has no astringent taste unique to iron and is excellent in iron absorption and anemia improvement effects.
The whey to be used is not particularly limited, and the whey produced during cheese and casein production may be reconstituted by dissolving the dried whey again in water.
As the iron source, iron compounds such as ferric chloride, ferric nitrate, and ferric sulfate can be usually used. For example, these are used in the form of an aqueous solution.

本発明の鉄添加WPCは、ホエーと、鉄イオンすなわち鉄源を含む溶液を混合し、常法より限外濾過して濃縮することによって製造できる。また、予めホエーを限外濾過で濃縮後に鉄イオンすなわち鉄源と混合してもよい。
このとき、混合する鉄イオンの重量はホエーに含まれるタンパク質の1/20以下、好ましくは1/250以下である。
鉄イオンを含む溶液、ホエーおよび/または鉄イオンと混合した後のホエー、すなわち、液状の鉄添加WPCは、水酸化ナトリウム、水酸化カリウム、塩酸、クエン酸、酢酸等を使用してpH調整することができ、通常、得られる液状の鉄添加WCPが、pH2〜9、好ましくは5.5以上となるように調整する。得られた液状の鉄添加WPCはそのままの状態で用いてもよく、また、常法に従って、凍結乾燥、噴霧乾燥等により乾燥し、粉末化して用いてもよい。
得られた鉄添加WPCは鉄独特の収斂味を有さず、鉄の吸収性、貧血改善効果に優れているという特徴を有するので、貧血の予防、改善、鉄強化を目的とした食品、医薬品、飼料等に添加する鉄強化用の鉄剤として有用である。
以下に実施例を挙げて本発明をさらに詳しく説明するが、本発明はこれらに限定されるものではない。
The iron-added WPC of the present invention can be produced by mixing whey and a solution containing iron ions, that is, an iron source, and concentrating by ultrafiltration using a conventional method. Alternatively, whey may be preliminarily concentrated by ultrafiltration and then mixed with iron ions, that is, an iron source.
At this time, the weight of the iron ions to be mixed is 1/20 or less, preferably 1/250 or less of the protein contained in the whey.
Solutions containing iron ions, whey and / or whey after mixing with iron ions, ie, liquid iron-added WPC, is adjusted to pH using sodium hydroxide, potassium hydroxide, hydrochloric acid, citric acid, acetic acid, etc. In general, the obtained liquid iron-added WCP is adjusted to have a pH of 2 to 9, preferably 5.5 or more. The obtained liquid iron-added WPC may be used as it is, or may be dried and pulverized by freeze-drying, spray-drying or the like according to a conventional method.
The obtained iron-added WPC does not have iron astringent taste, and has excellent iron absorption and anemia improvement effects. Therefore, foods and pharmaceuticals for the purpose of preventing and improving anemia and strengthening iron It is useful as an iron preparation for iron reinforcement added to feed and the like.
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.

ホエーとして、モッツァレラチーズホエーを使用した。このレンネットホエーをGP81PP膜(DOW DANMARK A/S社製、カットオフ10kDa)で限外濾過し、1/5に濃縮してホエータンパク質濃縮物(WPC)とした。これを2500×gで15分間遠心分離し、脂肪分を取り除いた。これに鉄が10mg/100mLとなるようにFeCl・6HOを添加した。得られた液状の混合物のpHは5.73であった。この混合物を凍結乾燥して鉄添加WCPを得た。
得られたサンプルを水に溶解し、カットオフ10kDaで限外濾過を行い、濾液中の鉄を測定した。原液中の鉄含量から濾液中の鉄含量を差し引いた値をタンパク質鉄含量とした。添加した鉄の90%が結合していた。鉄添加WPC中のタンパク質と鉄の関係を明らかにするため、Sephadex G−50を用いたゲル濾過により鉄添加WPCの溶出パターンを調べ、さらに各溶出画分の鉄の定量およびタンパク質の同定をそれぞれ原子吸光分光分析、SDS−PAGEにより行った。ゲル濾過により溶出するタンパク質を280nmの吸光度でスキャンしたものと、その溶出液中の鉄含量を測定した結果を図1に示した。SDS−PAGEの結果と溶出パターンを比較し、ピーク1を牛血清アルブミン(BSA)とラクトフェリン(Lf)、ピーク2をβ−ラクトグロブリン(β−Lg)、ピーク3をα−ラクトアルブミン(α−Lg)と同定した。この結果と鉄の溶出パターンとを比べると、鉄はβ−Lg、α−Laに多く結合していることがわかった。
As whey, mozzarella cheese whey was used. This rennet whey was ultrafiltered with a GP81PP membrane (manufactured by DOW DANMARK A / S, cutoff 10 kDa) and concentrated to 1/5 to obtain a whey protein concentrate (WPC). This was centrifuged at 2500 × g for 15 minutes to remove fat. Iron was added FeCl 3 · 6H 2 O as a 10 mg / 100 mL thereto. The pH of the obtained liquid mixture was 5.73. This mixture was freeze-dried to obtain iron-added WCP.
The obtained sample was dissolved in water, ultrafiltered at a cutoff of 10 kDa, and iron in the filtrate was measured. The value obtained by subtracting the iron content in the filtrate from the iron content in the stock solution was defined as the protein iron content. 90% of the added iron was bound. In order to clarify the relationship between protein and iron in iron-added WPC, the elution pattern of iron-added WPC was examined by gel filtration using Sephadex G-50. Atomic absorption spectroscopic analysis was performed by SDS-PAGE. FIG. 1 shows the results of scanning the protein eluted by gel filtration at an absorbance of 280 nm and measuring the iron content in the eluate. SDS-PAGE results and elution patterns were compared. Peak 1 was bovine serum albumin (BSA) and lactoferrin (Lf), peak 2 was β-lactoglobulin (β-Lg), and peak 3 was α-lactalbumin (α- Lg). When this result was compared with the elution pattern of iron, it was found that iron was bound to a large amount of β-Lg and α-La.

貧血モデルラットを用いて実施例1で調製した鉄添加WPCの鉄欠乏状態改善効果について、その他の鉄強化剤(FeSO)と比較検討した。3週齢のウィスター系雄ラットに3週間鉄欠飼料を与え、貧血状態にさせた。その後、鉄源がそれぞれ鉄添加WPC、FeSOから成る飼料を3週間与え、貧血改善効果を比較した。対照区として鉄欠乏食を与えず市販の固形食を与えた非貧血群、試験食投与期間も鉄欠乏食を与えた鉄欠食群を用いた。図2に試験食投与後の血清鉄濃度を、図3に試験食投与後の肝臓鉄含量を示した。
図中、a,bは1%レベルでの有意差を示す。
試験食投与後の血清鉄濃度は鉄添加WPC食群の方がFeSO食群よりも高い傾向にあった。試験食投与後の肝臓鉄含量は鉄添加WPC食群の方がFeSO食群よりも有意に高い結果となった。これらのことから、鉄添加WPIの方がFeSO4に比べラットの体内に蓄積される鉄含量が高いと言える。よって、鉄添加WPCは貧血改善のための食品素材として有用である。
The iron deficient state improving effect of the iron-added WPC prepared in Example 1 using an anemia model rat was compared with other iron reinforcing agents (FeSO 4 ). Three-week-old Wistar male rats were fed an iron-deficient diet for 3 weeks to be anemic. Thereafter, feeds each consisting of iron-added WPC and FeSO 4 were given for 3 weeks, and the anemia-improving effect was compared. As a control group, a non-anemic group in which a commercially available solid diet was given without giving an iron-deficient diet, and an iron-deficient group in which an iron-deficient diet was given during the test diet administration period were used. FIG. 2 shows the serum iron concentration after administration of the test meal, and FIG. 3 shows the liver iron content after administration of the test meal.
In the figure, a and b indicate significant differences at the 1% level.
The serum iron concentration after administration of the test diet tended to be higher in the iron-added WPC diet group than in the FeSO 4 diet group. The liver iron content after administration of the test meal was significantly higher in the iron-added WPC diet group than in the FeSO 4 diet group. From these facts, it can be said that iron-added WPI has a higher iron content accumulated in the rat body than FeSO4. Therefore, iron-added WPC is useful as a food material for improving anemia.

実施例1で調製した鉄添加WPCの吸収性を評価するためにCaco−2細胞を用いたin vivo試験を行った。6−ウエル・プレートにCaco−2細胞を50,000個/cmの濃度で播種し、10%FCSを含むDMEMで14日間培養したものを吸収性試験に用いた。鉄吸収試験はMEM無血清培地を用いて行った。ペプシンおよびパンクレアチンで人工消化した鉄添加WPCを鉄濃度が50μMおよび100μMとなるようMEM無血清培地に添加し、24時間培養後、PBSで2回洗浄し、ラバーポリスマンで細胞を剥離した。回収した細胞を超音波で破砕し、フェリチン(ferritin)含量を測定した。WPCに含まれるラクトフェリン(LF)には細胞増殖促進作用があることが知られているのでタンパク質含量を測定した。フェリチン含量をタンパク質含量で補正した結果を図4に示した。
図中、Blankは鉄欠乏区、FeSO4は、硫酸第一鉄添加区、Whey Feは鉄添加WPC添加区、**は1%レベルでの有意差を示す。
Caco−2細胞のフェリチン含量はいずれの鉄濃度でも鉄添加WPCの方がFeSOに比べ有意に高い値を示した。このことから、鉄添加WPC中の鉄はFeSOに比べて吸収性に優れていると考えられる。動物実験で見られた鉄添加WPCの貧血改善はこの易吸収性を反映した結果であると考えられる。
In order to evaluate the absorbability of iron-added WPC prepared in Example 1, an in vivo test using Caco-2 cells was performed. A 6-well plate was seeded with Caco-2 cells at a concentration of 50,000 cells / cm 2 and cultured in DMEM containing 10% FCS for 14 days. The iron absorption test was performed using MEM serum-free medium. Iron-added WPC artificially digested with pepsin and pancreatin was added to a MEM serum-free medium so that the iron concentration was 50 μM and 100 μM, cultured for 24 hours, washed twice with PBS, and cells were detached with a rubber policeman. The collected cells were sonicated and the ferritin content was measured. Since lactoferrin (LF) contained in WPC is known to have a cell growth promoting action, the protein content was measured. The result of correcting the ferritin content by the protein content is shown in FIG.
In the figure, Blank represents an iron-deficient group, FeSO 4 represents a ferrous sulfate-added group, Whey Fe represents an iron-added WPC-added group, and ** represents a significant difference at a 1% level.
The ferritin content of Caco-2 cells was significantly higher in iron-added WPC than in FeSO 4 at any iron concentration. From this, it is considered that the iron in the iron-added WPC is superior in absorbability compared to FeSO 4 . It is considered that the improvement of anemia of iron-added WPC observed in animal experiments is a result of reflecting this easy absorption.

実施例1で調製した鉄添加WPCを鉄濃度が10mg%となるように水に溶解したものの官能試験を行った。男5名女3名のパネラーに鉄の収斂味を感じるか否かを判定させた。なお、鉄の収斂味を感じる試料として、鉄濃度が10mg%の硫酸第一鉄水溶液についても同様に官能試験を行った。その結果、パネラー全員が硫酸第一鉄水溶液は鉄の収斂味を感じると判定したのに対して、鉄添加WPCはパネラー全員が鉄の収斂味を感じないと判定した。   A sensory test was performed on the iron-added WPC prepared in Example 1 dissolved in water so that the iron concentration was 10 mg%. Panelists of 5 males and 3 females were asked to determine whether they felt the astringent taste of iron. In addition, the sensory test was similarly performed about the ferrous sulfate aqueous solution whose iron concentration is 10 mg% as a sample which feels the astringency of iron. As a result, all panelists determined that the ferrous sulfate aqueous solution felt the astringent taste of iron, whereas iron-added WPC determined that all panelists did not feel the astringent taste of iron.

本発明によれば、飲食品、飼料等に添加する水不溶性もしくは難溶性ミネラルである鉄の使用にあたって、極めて水に溶けやすい性質を有しており、鉄独特の収斂味を示さず、吸収性・貧血改善効果に優れた、鉄強化、貧血の予防または治療を目的とした食品、医薬品、飼料等の原料として有用な鉄強化素材用の鉄剤を提供することができる。   According to the present invention, when using iron which is a water-insoluble or sparingly soluble mineral to be added to foods and drinks, feeds, etc., it has a property that it is extremely soluble in water, does not show astringent taste unique to iron, and absorbs -It is possible to provide an iron preparation for an iron-enhancing material that is excellent as an anemia-improving effect and is useful as a raw material for foods, pharmaceuticals, feeds, etc., for the purpose of iron strengthening and prevention or treatment of anemia.

実施例1で調製した鉄添加WPCのゲル濾過溶出パターンとその溶出液中の鉄濃度を示すグラフである。It is a graph which shows the gel filtration elution pattern of the iron addition WPC prepared in Example 1, and the iron concentration in the eluate. 実施例1で調製した鉄添加WPCを貧血モデルラットに投与した後の血清鉄濃度を示すグラフである。It is a graph which shows the serum iron density | concentration after administering the iron addition WPC prepared in Example 1 to an anemia model rat. 実施例1で調製した鉄添加WPCを貧血モデルラットに投与した後の肝臓鉄濃度を示すグラフである。It is a graph which shows the liver iron density | concentration after administering the iron addition WPC prepared in Example 1 to an anemia model rat. Caco−2細胞のフェリチン含量に及ぼす鉄添加WPCの影響を示すグラフである。It is a graph which shows the influence of iron addition WPC on the ferritin content of Caco-2 cell.

Claims (3)

ホエータンパク質1重量部当たり、0.001〜0.05重量部の鉄を含有し、ホエータンパク質と鉄とが複合体を形成し、鉄の収斂味を有さα−ラクトアルブミンが豊富化されていないpH5.5以上の液状またはその乾燥物であることを特徴とする鉄の吸収性、貧血改善効果用鉄添加ホエータンパク質濃縮物。 Contains 0.001-0.05 parts by weight of iron per 1 part by weight of whey protein, whey protein and iron form a complex, does not have iron astringent taste, and is enriched with α-lactalbumin An iron-added whey protein concentrate for improving iron absorptivity and anemia, characterized by being not liquid and having a pH of 5.5 or higher or a dried product thereof. ホエーと、鉄イオンを含む水溶液を混合して限外濾過するか、限外濾過したホエーと、鉄イオンを混合することを特徴する請求項1記載の鉄添加ホエータンパク質濃縮物の製造法。 2. The method for producing an iron-added whey protein concentrate according to claim 1, wherein whey and an aqueous solution containing iron ions are mixed and subjected to ultrafiltration, or ultrafiltered whey and iron ions are mixed. 鉄イオンの重量がホエー中のタンパク質の1/20以下、得られるホエーと鉄イオンの液状混合物のpHが5.5以上である請求項2の製造法。 The method according to claim 2, wherein the weight of iron ions is 1/20 or less of the protein in whey, and the pH of the resulting liquid mixture of whey and iron ions is 5.5 or more.
JP2005185338A 2005-06-24 2005-06-24 Iron-added whey protein concentrate and method for producing the same Expired - Fee Related JP4119440B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005185338A JP4119440B2 (en) 2005-06-24 2005-06-24 Iron-added whey protein concentrate and method for producing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005185338A JP4119440B2 (en) 2005-06-24 2005-06-24 Iron-added whey protein concentrate and method for producing the same

Publications (2)

Publication Number Publication Date
JP2007000094A JP2007000094A (en) 2007-01-11
JP4119440B2 true JP4119440B2 (en) 2008-07-16

Family

ID=37686254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005185338A Expired - Fee Related JP4119440B2 (en) 2005-06-24 2005-06-24 Iron-added whey protein concentrate and method for producing the same

Country Status (1)

Country Link
JP (1) JP4119440B2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6932687B2 (en) * 2016-03-07 2021-09-08 雪印メグミルク株式会社 Whey protein fractionation method, method for producing a composition containing α-lactalbumin, and method for producing a composition containing β-lactoglobulin.
JP2018131417A (en) * 2017-02-16 2018-08-23 株式会社明治 Anemia preventing/improving composition
CN114014907A (en) * 2021-10-09 2022-02-08 浙江大学 Preparation method and application of fish skin oligopeptide chelated iron
CN114027507B (en) * 2021-11-18 2023-02-28 中国农业大学 Oral gel iron supplement and preparation method thereof

Also Published As

Publication number Publication date
JP2007000094A (en) 2007-01-11

Similar Documents

Publication Publication Date Title
Hurrell et al. Iron absorption in humans as influenced by bovine milk proteins
Camara-Martos et al. Influence of dietary factors on calcium bioavailability: a brief review
Stapleton et al. Taurine and human nutrition
Lönnerdal Nutritional aspects of soy formula
Jackson et al. The effect of dairy products on iron availability
NZ197660A (en) Protein-fortified beverage composition
JP2007246413A (en) Composition containing milk-originated basic protein
AU761145B2 (en) Calcium complex and food fortified therewith
NZ566690A (en) Milk derived composition and use to enhance muscle mass or muscle strength
Azuma et al. Stimulatory effect of human lactoferrin on DNA synthesis in BALB/c 3T3 cells
JP4119440B2 (en) Iron-added whey protein concentrate and method for producing the same
JP2808166B2 (en) Manufacturing method of iron-fortified beverage
JP3387643B2 (en) How to reduce casein odor
JP2918069B2 (en) Dietary foods for patients with renal failure
JP2007022989A (en) Anti-fatigue agent
Roth et al. Utilization of zinc from picolinic or citric acid complexes in relation to dietary protein source in rats
Zhang et al. Bioavailability of iron-milk-protein complexes and fortified cheddar cheese
JP2818827B2 (en) Iron supplement drink
JP3596695B2 (en) Iron-casein complex and method for producing the same
JP4191261B2 (en) Iron casein complex and its production method
DE69907823T3 (en) Process for the preparation of an iron whey proteolysate complex
JPH03240437A (en) Prepared milk resemble to human milk
JP2735375B2 (en) Iron agent, its manufacturing method and iron-fortified food manufacturing method
JP3580517B2 (en) Iron casein phosphopeptide complex and method for producing the same
Nelson Jr et al. Effect of pH on the speciation and solubility of divalent metals in human and bovine milks

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20070306

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070424

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20070626

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070824

A911 Transfer of reconsideration by examiner before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20070905

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080122

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080415

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080424

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110502

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees